Progesterone and Miscarriage: What Trials Show
SaveProgesterone does not prevent miscarriage for most people. Large trials found no benefit when it is given routinely for unexplained recurrent loss, but a subgroup with both early bleeding and prior miscarriages may gain a modest benefit, which is why some guidelines offer it selectively.
Last updated: July 2026
Does progesterone prevent miscarriage?
Progesterone is the hormone that maintains the uterine lining in early pregnancy, so supplementing it has long seemed logical after a loss. The best current evidence, however, shows it does not prevent miscarriage for most people 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. About 1 in 10 recognized pregnancies ends in loss, and roughly 50% of those losses trace to random chromosome errors that no hormone can fix 3Ref 3American College of Obstetricians and Gynecologists (2018).ACOG Practice Bulletin No. 200: Early Pregnancy Loss.About 1 in 10 recognized pregnancies ends in miscarriage and about half of losses are caused by random chromosome errors that hormonal support cannot change.
According to reproductive medicine guidance, routine progesterone is not recommended for unexplained recurrent loss because trials did not show it raises live-birth rates overall 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. The nuance is in the subgroups, which is where the widely cited studies come in. Understanding those results helps separate hope from proof.
What did the PROMISE and PRISM trials find?
The PROMISE trial tested vaginal progesterone in over 800 women with unexplained recurrent miscarriage and found no significant improvement in live-birth rates compared with placebo 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. That result pushed back against decades of routine prescribing.
The PRISM trial then studied more than 4,000 women with early-pregnancy bleeding, a threatened miscarriage. Overall, progesterone again did not significantly raise live births across the whole group. But a pre-planned subgroup, women who had bleeding and 3 or more previous miscarriages, showed a possible benefit 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found2Ref 2National Institute for Health and Care Excellence (2026).Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126).Recommendation to offer vaginal micronized progesterone to women with early-pregnancy bleeding and a history of previous miscarriage, based on the PRISM subgroup. Because subgroup findings can arise by chance, guidelines treat this as reasonable but not definitive. National guidance in the United Kingdom translated it into an offer of vaginal micronized progesterone for women with bleeding and at least one prior loss 2Ref 2National Institute for Health and Care Excellence (2026).Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126).Recommendation to offer vaginal micronized progesterone to women with early-pregnancy bleeding and a history of previous miscarriage, based on the PRISM subgroup.
Who might actually benefit from progesterone?
The people most likely to benefit are those with current early-pregnancy bleeding plus a history of one or more previous miscarriages, based on the PRISM subgroup 2Ref 2National Institute for Health and Care Excellence (2026).Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126).Recommendation to offer vaginal micronized progesterone to women with early-pregnancy bleeding and a history of previous miscarriage, based on the PRISM subgroup. For them, some clinicians offer vaginal micronized progesterone through the first 12 weeks as a low-risk trial. The expected gain is modest, not a guarantee.
For women with no bleeding, or with a first pregnancy and no prior loss, the trials provide no support for progesterone 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. It is also worth separating this from fertility-clinic protocols: progesterone is standard luteal support after IVF because those cycles suppress natural hormone production, which is a different situation. If you are unsure whether bleeding is significant, our page on spotting in early pregnancy offers context.
What are the risks and limits of the evidence?
Vaginal micronized progesterone is generally well tolerated, with side effects like discharge, breast tenderness, or drowsiness, and no clear signal of harm to the pregnancy in the trials 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. The main limit is not safety but effectiveness: outside the bleeding-plus-prior-loss subgroup, it simply has not been shown to work 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found.
Another limit is that progesterone treats a presumed hormonal shortfall, yet most recurrent losses are not caused by low progesterone. A structured workup often finds other contributors, from uterine shape to clotting issues, as our guide to clotting-disorder testing describes. Preconception planning also matters across the reproductive lifespan, and our overview of trying again after a loss walks through readiness 4Ref 4American College of Obstetricians and Gynecologists (2019).ACOG Committee Opinion No. 762: Prepregnancy Counseling.Preconception planning and readiness across the reproductive lifespan as the frame for decisions after a loss.
When recurrent miscarriage needs a specialist
Two or more miscarriages, or early bleeding in a pregnancy after prior losses, is a reasonable point to see a gynecologist or reproductive endocrinologist who can weigh whether progesterone fits your situation 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. A specialist can also order the broader recurrent-loss evaluation rather than relying on a hormone alone, and our page on how many miscarriages before testing explains the usual thresholds.
Recurrent loss affects roughly 1% to 2% of couples, and in more than half of cases no single cause is found, which makes evidence-based expectations important 1Ref 1Practice Committee of the American Society for Reproductive Medicine (2026).Recurrent pregnancy loss: a committee opinion.Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found. According to reproductive medicine guidance, progesterone is one tool with a narrow proven role, not a universal fix. Gale can help you prepare questions for that visit.
Common questions
Related
Fertility & conception
Low-Dose Aspirin and Pregnancy Loss: The EvidenceFertility & conception
Grieving a Miscarriage: When the Loss Feels InvisibleFertility & conception
Short Luteal Phase: Does It Affect Getting Pregnant?
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to seek review about progesterone and loss
- —Early-pregnancy bleeding in someone with prior miscarriages is a reason to seek prompt clinician review to discuss options
- —Two or more miscarriages is a reason to ask a specialist about a full recurrent-loss workup rather than a hormone alone
- —Heavy bleeding soaking a pad an hour, fever, or severe pelvic pain is a reason to seek same-day urgent evaluation
- —Severe one-sided pain, shoulder-tip pain, or fainting is a reason to seek emergency care for possible ectopic pregnancy
- —Persistent anxiety or grief across pregnancies is a reason to reach out to a clinician or counselor for support
This article is general health education, not medical advice. Whether progesterone is appropriate for your situation depends on your history and should be decided with a gynecologist or reproductive endocrinologist.
References
- 1.Practice Committee of the American Society for Reproductive Medicine (2026). Recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2026.03.001 ✓Routine progesterone is not recommended for unexplained recurrent loss because trials did not raise live-birth rates overall; trial subgroup nuance; safety and tolerability; recurrent loss affects 1-2% of couples with often no single cause found
- 2.National Institute for Health and Care Excellence (2026). Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126). National Institute for Health and Care Excellence (NICE). link ✓Recommendation to offer vaginal micronized progesterone to women with early-pregnancy bleeding and a history of previous miscarriage, based on the PRISM subgroup
- 3.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002899 ✓About 1 in 10 recognized pregnancies ends in miscarriage and about half of losses are caused by random chromosome errors that hormonal support cannot change
- 4.American College of Obstetricians and Gynecologists (2019). ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003013 ✓Preconception planning and readiness across the reproductive lifespan as the frame for decisions after a loss
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy